As of 2026-03-31, 威高集团有限公司's data on the DeepSeek platform in the 医药制造 category shows: The overall mention rate is 0.00%, below the industry average by 7.1 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 威高集团有限公司's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
威高集团有限公司's Mention Rate is 0.00%, lower than 0.6% of competitors
威高集团有限公司's First Mention is 0.00%, lower than 0.9% of competitors
威高集团有限公司's Preferred Rate is 0.00%, lower than 100.0% of competitors
威高集团有限公司's Positive Rate is 0.00%, lower than 8.9% of competitors
威高集团有限公司's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 恒恒瑞医药 | 71.64% | 22.39% | 40% | 65.67% | 7.46% | View Details |
| 百百济神州 | 67.16% | 11.94% | 0% | 59.7% | 1.49% | View Details |
| 罗罗氏 | 41.79% | 1.49% | 5% | 35.82% | 1.49% | View Details |
| 药药明康德 | 41.79% | 0% | 0% | 31.34% | 1.49% | View Details |
| 中中国生物制药 | 40.3% | 0% | 0% | 29.85% | 0% | View Details |
| 诺诺和诺德 | 34.33% | 0% | 0% | 29.85% | 8.96% | View Details |
| 威威高集团有限公司 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
